| Literature DB >> 25175408 |
Quan Shen, Yingyan Pu, Xingli Fu, Ying Xie, Xiaobo Bian, Shixing Yang, Yan Yang, Li Cui, Xiaochun Wang, Hua Wang, Wen Zhang1.
Abstract
BACKGROUND: Our understanding of Hepatitis E virus (HEV) has changed enormously over the past 30 years, from a waterborne infection causing outbreaks of acute hepatitis in developing countries to an infection of global distribution causing a range of hepatic and extra-hepatic illness. However, the key proteins playing important parts in the virus infection were still unknown. Understanding the changes of cellular proteins in these cells exposed to HEV is helpful for elucidating molecular mechanisms associated with function alterations of HEV-infected susceptible cells. In the present study, a comparative gel-based proteomic analysis was employed to study the changes in cellular proteins of A549 exposed to HEV in vitro to provide novel information for understanding the functional alterations of A549 induced by HEV infection. RESULT: Of 2 585-3 152 protein spots visualized on each gel using silver staining, a total of 31 protein spots were found to be differentially expressed in HEV-infected A549 cells compared with mock-infected A549, including 10 significantly up-regulated protein spots and 21 significantly down-regulated protein spots.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25175408 PMCID: PMC4236826 DOI: 10.1186/s12917-014-0188-5
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Figure 1The CEP of A549 cells at 24 h (B) or on day 6 (C) post-infection, cells treated with HEV negative swine fecal sample as control (A); (blow) the structural changes of A549 cells infected with HEV were investigated by TEM (40,000 ×) (D), cells treated with HEV negative swine fecal sample as control (E).
Figure 2Detection of HEV RNA (A), Virus Particles (B) and Antigens (C) in infected cells with RT-PCR, Dot-blot and unlabeled immune Electron Microscopy, respectively. A: 1, infected A549 cells. 2, HEV negative fecal sample inoculated cells. P, HEV positive fecal sample as control; B: F, HEV positive fecal sample. P, HEV inoculated A549 cells. C, HEV negative fecal sample inoculated cells; C, black arrow indicated complete virus particle and white arrow indicated empty virus particle.
Figure 32-DE analysis of the total proteins of control (A) and HEV infected A549 cell (B), and the protein dots with difference between the control and infected A549 cells (C). Arrows indicated the isolated and identified protein spots.
Figure 4Confirmation of two differentially expressed proteins, MAPK4 (left) and HSP70 (right) in control and HEV infected A549 cells by Western Blot assay. 1: control A549 cells; 2: HEV infected A549 cells.
Identification of differentially expressed cellular proteins in HEV-infected A549 cells
| 2038 (22) | L-lactate dehydrogenase A-like | 93 | NP_001266265 |
| 2509 (27) | Triosephosphate isomerase | 91 | AEE79384 |
| 2352 (10) | Cathepsin D precursor | 46 | NP_599161 |
| 2755 (30) | manganese superoxide dismutase isoform B▲ | 90 | NP_001019637 |
| 2556 (29) | Hypoxanthine-guanine phosphoribosyltransferase | 83 | NP_000185 |
| 1624 (20) | 2-phosphopyruvate-hydratase alpha-enolase | 94 | CAA59331 |
| 2130 (21) | Carboxylesterase▲ | 79 | AAB03611 |
| 2351 (8) | Chain B, Cathepsin D | 84 | P14091 |
| 1268 (18) | Chain A, Pyruvate Kinase M2 ▲ | 78 | 3H6O_B |
| 714 (13) | Isoform 1 of Filamin-B | 69 | NP_001157789 |
| 891 (1) | FLNA filamin A, | 60 | BAJ83965 |
| 1770 (5) | Calponin-3 ▲ | 83 | NP_001830 |
| 2245 (24) | Actin, cytoplasmic 1 | 71 | NP_001092 |
| 2885 (12) | ACTA2 Actin, aortic smooth muscle | 79 | NP_001604 |
| 2754 (11) | Keratin, type I cytoskeletal 9 | 68 | NP_000217 |
| 1400 (2) | 26S protease regulatory subunit 6B▲ | 42 | NP_006494 |
| 989 (15) | T-complex protein 1 subunit alpha | 58 | P17987 |
| 519 (14) | ATP-dependent RNA helicase | 83 | AAP97252 |
| 1267 (17) | Heterogeneous nuclear ribonucleoprotein H▲ | 69 | NP_005511 |
| 1693 (4) | Heat shock-related 70 kDa protein 2 | 60 | NP_068814 |
| 2328 (9) | PHB Prohibitin | 49 | P35232 |
| 1326 (19) | mitogen-activated protein kinase 9 ▲ | 68 | AAH32539 |
| 1448 (3) | Mitogen-activated protein kinase 4▲ | 92 | NP_002738 |
| 2302 (26) | NXA4 annexin IV | 50 | P09525 |
| 2702 (28) | Vacuolar ATP synthase catalytic subunit A | 90 | ADM12616 |
| 2193 (23) | annexin A1 | 88 | NP_000691 |
| 2291 (25) | Proliferation-associated protein 2G4 | 90 | NP_006182 |
Note: Black triangles indicated up-regulated proteins.